{
  "id" : "lymphoma_ocular_adnexa",
  "algorithm" : "eod_public",
  "version" : "3.3",
  "name" : "Lymphoma Ocular Adnexa",
  "title" : "Lymphoma Ocular Adnexa",
  "notes" : "9590-9699, 9702-9719, 9725-9726, 9734-9738, 9823, 9826-9827, 9930 (C441, C690, C695-C696)\n\n**Note 1:** **Sources used in the development of this schema**\n* SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf)\n* SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/ssm2000/)\n* Collaborative Stage Data Collection System, version 02.05:  https://cancerstaging.org/cstage/Pages/default.aspx \n* Chapter 71 *Ocular Adnexal Lymphoma*, in the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Used with permission of the American College of Surgeons, Chicago, Illinois.\n\n**Note 2:** **Origination of Ocular Adnexal Lymphomas** \n* Ocular adnexal lymphomas (OAL) originate in conjunctiva, eyelids, lacrimal gland, lacrimal drainage apparatus, and other orbital tissues surrounding the eye. This schema should not be used for secondary lymphomatous involvement of ocular adnexa or for intraocular lymphomas.\n\n**Note 3:** **Schema includes the preferred terms based on the 2024 WHO Classification of Tumours, Haematolymphoid tumors, 5th edition**",
  "schema_selection_table" : "schema_selection_lymphoma_ocular_adnexa",
  "inputs" : [ {
    "key" : "year_dx",
    "name" : "Year of Diagnosis",
    "naaccr_item" : 390,
    "naaccr_xml_id" : "dateOfDiagnosis",
    "table" : "year_dx_validation",
    "used_for_staging" : false
  }, {
    "key" : "site",
    "name" : "Primary Site",
    "naaccr_item" : 400,
    "naaccr_xml_id" : "primarySite",
    "table" : "primary_site",
    "used_for_staging" : true
  }, {
    "key" : "hist",
    "name" : "Histology",
    "naaccr_item" : 522,
    "naaccr_xml_id" : "histologicTypeIcdO3",
    "table" : "histology",
    "used_for_staging" : true
  }, {
    "key" : "reporting_source",
    "name" : "Type of Reporting Source",
    "naaccr_item" : 500,
    "naaccr_xml_id" : "typeOfReportingSource",
    "table" : "type_of_reporting_source_76696",
    "used_for_staging" : false
  }, {
    "key" : "size_clin",
    "name" : "Tumor Size Clinical",
    "naaccr_item" : 752,
    "naaccr_xml_id" : "tumorSizeClinical",
    "table" : "tumor_size_clinical_60979",
    "used_for_staging" : false
  }, {
    "key" : "size_path",
    "name" : "Tumor Size Pathological",
    "naaccr_item" : 754,
    "naaccr_xml_id" : "tumorSizePathologic",
    "table" : "tumor_size_pathological_25597",
    "used_for_staging" : false
  }, {
    "key" : "size_summary",
    "name" : "Tumor Size Summary",
    "naaccr_item" : 756,
    "naaccr_xml_id" : "tumorSizeSummary",
    "default" : "999",
    "table" : "tumor_size_summary_63115",
    "used_for_staging" : false
  }, {
    "key" : "nodes_pos",
    "name" : "Regional Nodes Positive",
    "naaccr_item" : 820,
    "naaccr_xml_id" : "regionalNodesPositive",
    "default" : "99",
    "table" : "nodes_pos_fpa",
    "used_for_staging" : false
  }, {
    "key" : "nodes_exam",
    "name" : "Regional Nodes Examined",
    "naaccr_item" : 830,
    "naaccr_xml_id" : "regionalNodesExamined",
    "default" : "99",
    "table" : "nodes_exam_76029",
    "used_for_staging" : false
  }, {
    "key" : "neoadjuvant_therapy",
    "name" : "Neoadjuvant Therapy",
    "naaccr_item" : 1632,
    "naaccr_xml_id" : "neoadjuvantTherapy",
    "default" : "9",
    "table" : "neoadjuvant_therapy_37302",
    "used_for_staging" : false,
    "metadata" : [ {
      "name" : "SEER_REQUIRED",
      "start" : 2021
    } ]
  }, {
    "key" : "neoadj_tx_clinical_response",
    "name" : "Neoadjuvant Therapy – Clinical Response",
    "naaccr_item" : 1633,
    "naaccr_xml_id" : "neoadjuvTherapyClinicalResponse",
    "default" : "9",
    "table" : "neoadj_tx_clinical_response_31723",
    "used_for_staging" : false,
    "metadata" : [ {
      "name" : "SEER_REQUIRED",
      "start" : 2021
    } ]
  }, {
    "key" : "neoadj_tx_treatment_effect",
    "name" : "Neoadjuvant Therapy – Treatment Effect",
    "naaccr_item" : 1634,
    "naaccr_xml_id" : "neoadjuvTherapyTreatmentEffect",
    "default" : "9",
    "table" : "neoadj_tx_treatment_effect_18122",
    "used_for_staging" : false,
    "metadata" : [ {
      "name" : "SEER_REQUIRED",
      "start" : 2021
    } ]
  }, {
    "key" : "eod_primary_tumor",
    "name" : "EOD Primary Tumor",
    "naaccr_item" : 772,
    "naaccr_xml_id" : "eodPrimaryTumor",
    "default" : "999",
    "table" : "extension_bez",
    "used_for_staging" : true
  }, {
    "key" : "eod_regional_nodes",
    "name" : "EOD Regional Nodes",
    "naaccr_item" : 774,
    "naaccr_xml_id" : "eodRegionalNodes",
    "default" : "999",
    "table" : "seer_regional_nodes_27397",
    "used_for_staging" : true
  }, {
    "key" : "eod_mets",
    "name" : "EOD Mets",
    "naaccr_item" : 776,
    "naaccr_xml_id" : "eodMets",
    "default" : "00",
    "table" : "seer_mets_90003",
    "used_for_staging" : true
  }, {
    "key" : "ss2018",
    "name" : "SS2018",
    "naaccr_item" : 764,
    "naaccr_xml_id" : "summaryStage2018",
    "table" : "ss2018_lymphoma_ocular_adnexa_3583",
    "used_for_staging" : false
  }, {
    "key" : "grade_clin",
    "name" : "Grade Clinical",
    "naaccr_item" : 3843,
    "naaccr_xml_id" : "gradeClinical",
    "default" : "9",
    "table" : "grade_clinical_19087",
    "used_for_staging" : true,
    "metadata" : [ {
      "name" : "COC_REQUIRED"
    }, {
      "name" : "NPCR_REQUIRED"
    }, {
      "name" : "SSDI"
    }, {
      "name" : "CCCR_REQUIRED"
    }, {
      "name" : "SEER_REQUIRED"
    } ]
  }, {
    "key" : "grade_path",
    "name" : "Grade Pathological",
    "naaccr_item" : 3844,
    "naaccr_xml_id" : "gradePathological",
    "default" : "9",
    "table" : "grade_pathological_49403",
    "used_for_staging" : true,
    "metadata" : [ {
      "name" : "COC_REQUIRED"
    }, {
      "name" : "NPCR_REQUIRED"
    }, {
      "name" : "SSDI"
    }, {
      "name" : "CCCR_REQUIRED"
    }, {
      "name" : "SEER_REQUIRED"
    } ]
  }, {
    "key" : "grade_post_therapy_clin",
    "name" : "Grade Post Therapy Clin (yc)",
    "naaccr_item" : 1068,
    "naaccr_xml_id" : "gradePostTherapyClin",
    "table" : "grade_post_therapy_clin_43459",
    "used_for_staging" : false,
    "metadata" : [ {
      "name" : "NPCR_REQUIRED"
    }, {
      "name" : "COC_REQUIRED"
    }, {
      "name" : "SSDI"
    }, {
      "name" : "SEER_REQUIRED"
    } ]
  }, {
    "key" : "grade_post_therapy_path",
    "name" : "Grade Post Therapy Path (yp)",
    "naaccr_item" : 3845,
    "naaccr_xml_id" : "gradePostTherapy",
    "table" : "grade_post_therapy_path_67342",
    "used_for_staging" : false,
    "metadata" : [ {
      "name" : "NPCR_REQUIRED"
    }, {
      "name" : "COC_REQUIRED"
    }, {
      "name" : "SSDI"
    }, {
      "name" : "CCCR_REQUIRED"
    }, {
      "name" : "SEER_REQUIRED"
    } ]
  } ],
  "outputs" : [ {
    "key" : "naaccr_schema_id",
    "name" : "Schema ID",
    "naaccr_item" : 3800,
    "naaccr_xml_id" : "schemaId",
    "default" : "00710"
  }, {
    "key" : "derived_version",
    "name" : "Derived Version",
    "default" : "{{ctx_alg_version}}"
  }, {
    "key" : "ss2018_derived",
    "name" : "Derived Summary Stage 2018",
    "naaccr_item" : 762,
    "naaccr_xml_id" : "derivedSummaryStage2018",
    "table" : "derived_ss2018_lymphoma_ocular_adnexa_92324",
    "default" : "9"
  }, {
    "key" : "derived_summary_grade",
    "name" : "Derived Summary Grade 2018",
    "naaccr_item" : 1975,
    "naaccr_xml_id" : "derivedSummaryGrade2018",
    "table" : "derived_grade_71063"
  } ],
  "mappings" : [ {
    "id" : "summary_stage_2018",
    "name" : "Summary Stage 2018",
    "tables" : [ {
      "id" : "combined_grade_56638",
      "inputs" : [ "grade_path", "grade_clin" ],
      "outputs" : [ "derived_summary_grade" ]
    }, {
      "id" : "extension_bez",
      "inputs" : [ "eod_primary_tumor" ],
      "outputs" : [ "ss2018_t" ]
    }, {
      "id" : "seer_regional_nodes_27397",
      "inputs" : [ "eod_regional_nodes" ],
      "outputs" : [ "ss2018_n" ]
    }, {
      "id" : "seer_mets_90003",
      "inputs" : [ "eod_mets" ],
      "outputs" : [ "ss2018_m" ]
    }, {
      "id" : "summary_stage_raa",
      "inputs" : [ "ss2018_m", "ss2018_n", "ss2018_t" ],
      "outputs" : [ "ss2018_derived" ]
    } ]
  } ],
  "involved_tables" : [ "neoadjuvant_therapy_37302", "schema_selection_lymphoma_ocular_adnexa", "summary_stage_raa", "nodes_pos_fpa", "seer_regional_nodes_27397", "neoadj_tx_clinical_response_31723", "histology", "nodes_exam_76029", "seer_mets_90003", "ss2018_lymphoma_ocular_adnexa_3583", "tumor_size_summary_63115", "combined_grade_56638", "grade_pathological_49403", "derived_ss2018_lymphoma_ocular_adnexa_92324", "extension_bez", "grade_post_therapy_clin_43459", "type_of_reporting_source_76696", "tumor_size_pathological_25597", "tumor_size_clinical_60979", "grade_post_therapy_path_67342", "neoadj_tx_treatment_effect_18122", "primary_site", "grade_clinical_19087", "derived_grade_71063", "year_dx_validation" ],
  "last_modified" : "2025-09-19T18:54:55.279Z",
  "on_invalid_input" : "CONTINUE"
}